Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer

Breast cancer (BC) is the most common malignancy in women worldwide, with approximately two‐thirds having hormone receptor‐positive (HR+) tumors. New endocrine therapy (ET) strategies include combining ET agents as well as adding inhibitors targeting growth factors, angiogenesis, the mechanistic tar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Pritchard, Kathleen I., Chia, Stephen K., Simmons, Christine, McLeod, Deanna, Paterson, Alexander, Provencher, Louise, Rayson, Daniel
Format: Artigo
Idioma:Inglês
Publicat: Wiley-Blackwell 2016
Matèries:
Breast Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5313264/
https://ncbi.nlm.nih.gov/pubmed/27864574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0185
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars